Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases (Q46931957)
Jump to navigation
Jump to search
scientific article published in December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases |
scientific article published in December 2007 |
Statements
1 reference
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases (English)
1 reference
Huamin Wang
1 reference
Dario Ribero
1 reference
Matteo Donadon
1 reference
Daria Zorzi
1 reference
Melanie B Thomas
1 reference
Cathy Eng
1 reference
David Z Chang
1 reference
Steven A Curley
1 reference
Eddie K Abdalla
1 reference
Lee M Ellis
1 reference
Jean-Nicolas Vauthey
1 reference
1 December 2007
1 reference
1 reference
110
1 reference
12
1 reference
2761-2767
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference